ライフサイエンスコーパス: multipotent

1 press the neural crest marker p75 and become multipotent.

2 tors in the injured retina are intrinsically multipotent.

3 actility (seeded on 2 mum gratings) remained multipotent.

4 ges, a large fraction of the progenitors are multipotent.

5 that individual neural crest precursors are multipotent.

6 hat at the population level Cux2(+) RGCs are multipotent.

7 ge/brown markers, suggesting the presence of multipotent adipogenic precursor cells.

8 lymers are used to deliver minicircle DNA to multipotent adipose derived stem cells (ADSCs) and astro

9 In human multipotent adipose-derived stem cell adipocytes, APOM e

10 ndent clinical trials, and in vitro in human multipotent adipose-derived stem cell adipocytes.

11 There was no difference between the multipotent adult progenitor cell group and placebo grou

12 n the groups (64 [99%] of 65 patients in the multipotent adult progenitor cell group vs 59 [97%] of 6

13 score of 8-20 to treatment with intravenous multipotent adult progenitor cells (400 million or 1200

14 Multipotent Adult Progenitor Cells (MAPC((R)) ) possess

15 In vitro, we show that human multipotent adult progenitor cells (MAPCs) have the abil

16 ations consisted of 65 patients who received multipotent adult progenitor cells and 61 patients who r

17 tients were randomly assigned (67 to receive multipotent adult progenitor cells and 62 to receive pla

18 Multipotent adult progenitor cells are a bone marrow-der

19 rolled, dose-escalation trial of intravenous multipotent adult progenitor cells in 33 centres in the

20 ved at 90 days in neurological outcomes with multipotent adult progenitor cells treatment, further cl

21 INTERPRETATION: Administration of multipotent adult progenitor cells was safe and well tol

22 t, well-tolerated, and safest single dose of multipotent adult progenitor cells, and if they were eff

23 potent murine cells spontaneously convert to multipotent adult spermatogonial-derived stem cells (MAS

24 Basal cells are multipotent airway progenitors that generate distinct ep

25 Berberine is an ancient multipotent alkaloid drug which derived from Coptis chin

26 tted cells are molecularly distinct, whereas multipotent and bipotent progenitors do not exhibit diff

27 While some progenitors are bona fide multipotent and contribute progeny to all major pancreat

28 stem cell, endothelial cell, monocyte), were multipotent and could differentiate into macrophage-like

29 ic stem cells and their differentiation into multipotent and downstream lymphoid-biased progenitors.

30 Here we show that multipotent and functional NC cells can be derived by in

31 derived hematopoietic stem cells that remain multipotent and give rise to a variety of lineage-specif

32 Cardiac progenitor cells are multipotent and give rise to cardiac endothelium, smooth

33 ve also uncovered the presence of a range of multipotent and lineage-restricted progenitor cells in t

34 ude that pro-centrioles/pro-basal bodies are multipotent and not committed to form either a 9+2 or 9+

35 Multipotent and pluripotent stem cells are potential sou

36 ng of viral and tissue-specific promoters in multipotent and pluripotent stem cells.

37 Results: We found that basal cells included multipotent and secretory primed subsets in control adul

38 Utilizing multipotent and self-renewing capabilities, hematopoieti

39 onal and population levels Fezf2(+) RGCs are multipotent and that at the population level Cux2(+) RGC

40 ad, only two progenitor classes predominate, multipotent and unipotent, with Er-Mk lineages emerging

41 Many glandular epithelia develop from multipotent basal stem cells (BSCs) that are replaced in

42 Recent evidence has elucidated how multipotent blood progenitors transform their identities

43 HSC compartment, including the existence of multipotent but megakaryocyte/platelet-biased HSCs.

44 stem cell-like ability to self-renew and the multipotent capacity to reconstitute the entire spectrum

45 induced pluripotent stem cell (iPSC)-derived multipotent cardiac progenitor (MCPs) cells and, in para

46 lex and highly regulated spatiotemporally by multipotent cardiac stem/progenitor cells (CPCs).

47 ese findings support ex vivo fucosylation of multipotent CD34(+) CB cells as a clinically feasible me

48 In humans, mast cells can be cultured from multipotent CD34(+) progenitor cells.

49 evelopment, the glycoprotein 2 (GP2) marks a multipotent cell population that will differentiate into

50 ine lineage-specification program within the multipotent cell population.

51 Normalized Nrf2/Keap1 signaling restores multipotent cell properties in dBMSCs through Sox2 expre

52 eneration through paracrine effects and as a multipotent cell source, and has received recent attenti

53 duced cell plasticity occurs via a transient multipotent cell state and that concomitant exposure to

54 both the sequence of lineage choices made by multipotent cells and to identify the genes influencing

55 Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into adipoc

56 in the early embryo from Brachyury-positive multipotent cells in the posterior-proximal region of th

57 we examined if the epicardium that contains multipotent cells is involved in this remodeling process

58 ralleled resolution and how the landscape of multipotent cells may be rather devoid of discrete struc

59 Perturbation of this balance in multipotent cells of the dermomyotome influences cell fa

60 Mesenchymal stem/stromal cells (MSCs) are multipotent cells that are emerging as the most promisin

61 The neural crest (NC) represents multipotent cells that arise at the interphase between e

62 Solid malignancies contain subsets of multipotent cells that grow as spheres and efficiently p

63 lexity of gene regulatory networks that lead multipotent cells to acquire different cell fates makes

64 possess a population of highly proliferative multipotent cells with in vitro multilineage differentia

65 ocrine-selective transcription in epithelial multipotent cells, nascent endocrine progenitors, and di

66 Mesenchymal stem cells (MSCs) are multipotent cells, which can give rise to variety of cel

67 that are characteristic of undifferentiated, multipotent cells.

68 lonal organoid cultures derived from primary multipotent cells.

69 unipotent, with Er-Mk lineages emerging from multipotent cells.

70 Cs derived from PDL and gingiva demonstrated multipotent characteristics, suggesting new therapeutic

71 product of its target gene HMGA1, encoding a multipotent chromatin modifier.

72 Further, multipotent compounds were discovered, characterized, an

73 n profiles of human cardiac derivatives from multipotent CPCs to intermediates and mature cardiac cel

74 hage colony-stimulating factor (GM-CSF) is a multipotent cytokine that prompts the proliferation of b

75 om exfoliated deciduous teeth (SHED) possess multipotent differentiation and immunomodulatory propert

76 ions due to their long-term self-renewal and multipotent differentiation capacities.

77 These cells were capable of multipotent differentiation in vitro, generating both ci

78 ing of the epigenetic programs necessary for multipotent differentiation of MSCs that may prove benef

79 genomic stability and the ability to undergo multipotent differentiation to the specific epithelia fr

80 ages and yet capable of self-replication and multipotent differentiation, being able to differentiate

81 ion and the balance between self-renewal and multipotent differentiation.

82 ives and their pharmacological evaluation as multipotent drugs for the treatment of Alzheimer's disea

83 The neural crest is a transient, multipotent embryonic cell population in vertebrates giv

84 Neural crest cells (NCCs) are migratory, multipotent embryonic cells that are unique to vertebrat

85 dels can be developed in situ from different multipotent embryonic cerebellar progenitor cells via co

86 Here we show that mouse Sox9(+) multipotent embryonic lung progenitors can be isolated a

87 y, mice with loss of both Sin3a and Sin3b in multipotent embryonic pancreatic progenitors had signifi

88 Immature multipotent embryonic peripheral glial cells, the Schwan

89 Multipotent epithelial cells with high Aldehyde dehydrog

90 romote the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle c

91 eveal the births of larval astrocytes from a multipotent glial lineage, their allocation to reproduci

92 antage of cells conditionally blocked at the multipotent haematopoietic progenitor stage to develop a

93 Here, we employed a cellular model of murine multipotent haematopoietic progenitors (Hoxb8-FL) to kno

94 The self-renewal capacity of multipotent haematopoietic stem cells (HSCs) supports bl

95 to support the maintenance and expansion of multipotent hematopoietic cells, i.e. hematopoietic stem

96 x/flox):Scl-Cre-ER(T)) and demonstrated that multipotent hematopoietic colonies form despite the abse

97 ne receptor CCR9 controls the immigration of multipotent hematopoietic progenitor cells into the thym

98 ents diagnosed with BCR-ABL1-positive ALL, a multipotent hematopoietic progenitor is affected by the

99 iver mutation in a bone marrow (BM)-resident multipotent hematopoietic progenitor, while low-risk, MS

100 Ddb1 is highly expressed in multipotent hematopoietic progenitors and its deletion l

101 ng mesoderm, hemogenic endothelium (HE), and multipotent hematopoietic progenitors.

102 ith downstream progenitors, including HE and multipotent hematopoietic progenitors.

103 poses a hierarchy in which a small number of multipotent hematopoietic stem cells (HSCs) maintain all

104 ion labels the most primitive subset of true multipotent HSCs.

105 nto immunocompromised mice the percentage of multipotent HSPCs within the engrafted HSPC population w

106 ed mice efficiently support the expansion of multipotent HSPCs.

107 ns supported the expansion or maintenance of multipotent HSPCs.

108 Multipotent human adipose-derived perivascular stem cell

109 le scaffolds capable of supporting growth of multipotent human bone marrow mesenchymal stem cells (hM

110 Recently, a subpopulation of multipotent human luminal cells defined by CD26 expressi

111 ansforming growth factor beta (TGFbeta) is a multipotent immunosuppressive cytokine.

112 dipose-derived stromal/stem cells (ASCs) are multipotent in nature that can be differentiated into va

113 scribe a protocol to generate expandable and multipotent induced cardiac progenitor cells (iCPCs) fro

114 use green fluorescent protein (GFP)-positive multipotent induced pluripotent stem cell (iPSC)-derived

115 After in vitro enzymatic inhibition assays, multipotent inhibitors showing potencies in the nanomola

116 vitro approaches cannot efficiently generate multipotent long-lived HSPCs.

117 We documented stable multipotent long-term hematopoietic clonal output of mon

118 man hematopoietic system, rare self-renewing multipotent long-term hematopoietic stem cells (LT-HSCs)

119 onal pioneering during B cell programming of multipotent lymphoid progenitors by restricting chromati

120 Our findings provide evidence of a multipotent lymphomyeloid HSC origin of SF3B1 mutations

121 memory formation depends on elucidating how multipotent memory precursor (MP) cells maintain develop

122 ess and application of mechanical stretch to multipotent mesenchymal cells stimulated the nuclear tra

123 During nephrogenesis, multipotent mesenchymal nephron progenitors develop into

124 yoblasts in embryos but is also expressed in multipotent mesenchymal progenitors.

125 The cardiac stroma contains multipotent mesenchymal progenitors.

126 Multipotent mesenchymal stem cells (MSCs) are important

127 omplexes to direct the fate determination of multipotent mesenchymal stem cells (MSCs).

128 ation consisting of mature white adipocytes, multipotent mesenchymal stem cells, committed progenitor

129 Multipotent Mesenchymal Stem/Stromal Cells (MSCs) are wi

130 llicular thyroid cancers and the presence of multipotent mesenchymal stem/stromal cells (MSCs) in non

131 imum (estimate+/-SE, 0.01+/-0.002; P<0.001), multipotent mesenchymal stromal cell colony maximum (est

132 Multipotent mesenchymal stromal cells (MSC) are a possib

133 Multipotent mesenchymal stromal cells (MSCs) are require

134 ce, we demonstrate expression exclusively in multipotent mesenchymal stromal cells (MSCs) in the bone

135 on is the most popular route for therapeutic multipotent mesenchymal stromal/stem cell (MSC) delivery

136 Presentations covered multipotent (mesenchymal and hematopoietic) and pluripot

137 opriate cell fate decisions to occur in this multipotent mesoderm lineage.

138 omprise the head and face are derived from a multipotent migratory progenitor cell population called

139 Insertion-site analyses revealed the multipotent nature of corrected HSCs and showed that the

140 (ESC)-based model yields high proportions of multipotent NC cells (expressing SOX10, PAX7 and TFAP2A)

141 with the appearance of highly patterned and multipotent NCCs in stem vertebrates.

142 Little is known about how multipotent nephron progenitor cells differentiate into

143 ion of the GRN underlying development of the multipotent neural crest (NC) embryonic cell population.

144 During embryonic development, multipotent neural crest cells are specified at the late

145 ved skilled forelimb function after grafting multipotent neural progenitor cells into sites of SCI.

146 In the developing retina, multipotent neural progenitors undergo unidirectional di

147 berant Wnt responses, that induce some early multipotent NKX2-1(+) progenitors to lose lung fate.

148 Multipotent Nkx2-1-positive lung epithelial primordial p

149 or the existence of a sortable population of multipotent non-epithelial cells in the adult pancreas t

150 oma function in vivo, which is mediated by a multipotent NT5E(+) (CD73)(+) ENG(-) (CD105)(-) LY6A(+)

151 monstrates that BMI1 is expressed in vivo by multipotent OE progenitors, validating our culture model

152 s do not require transit through a requisite multipotent or bipotent megakaryocyte-erythrocyte progen

153 ells produce all cells of an organism, while multipotent or unipotent stem cells regenerate only spec

154 n of nuclear peripheral heterochromatin as a multipotent P19 cell adopts either a neural or a cardiac

155 just the Swi/Snf Brg1 ATPase subunit reduced multipotent pancreatic progenitor cell proliferation and

156 Notch signaling controls proliferation of multipotent pancreatic progenitor cells (MPCs) and their

157 ping pancreata, indicating that it marks the multipotent pancreatic progenitors in vivo.

158 SMC-derived AdvSca1 cells exhibit a multipotent phenotype capable of differentiating in vivo

159 The neural crest is a transient, multipotent population of cells that arises at the borde

160 NMP-like cells in vitro initially produce a multipotent population that, in addition to NMPs, genera

161 hich have been proposed to arise either from multipotent precursor cells or pools of heterogeneous, r

162 l checkpoints that dictate the commitment of multipotent precursors to the T cell lineage and their s

163 transition from naive/primed pluripotency to multipotent primary neural progenitor cells (NPCs).

164 ing of changes with age in the heterogeneous multipotent progenitor (MPP) cell compartment, which is

165 surrounding genes specifically expressed in multipotent progenitor (MPP) cells and HSCs (P <= 3.5 x

166 rease in hematopoietic stem cells (HSCs) and multipotent progenitor (MPP) cells in conditional Runx1-

167 regeneration involving the remodeling of the multipotent progenitor (MPP) compartment downstream of h

168 SC numbers and a concomitant increase in the multipotent progenitor (MPP) compartment.

169 CL12, but whether a separate niche instructs multipotent progenitor (MPP) differentiation remains unc

170 nalyses suggest that LumP and PrU cells have multipotent progenitor activity in organoid formation an

171 Within the epithelium, a multipotent progenitor cell (MPC) population is specifie

172 s the effects of the loss of Dok proteins on multipotent progenitor cell cycle.

173 The stem cell factor-dependent multipotent progenitor cell line HPC-7 represents a well

174 of JMML using mice that express KrasG12D in multipotent progenitor cells (Flt3Cre+ KrasG12D mice).

175 By contrast, multipotent progenitor cells (MPPs) show greater variati

176 roles in the migration and specification of multipotent progenitor cells at the onset of cardiogenes

177 capacity to predict and control when and how multipotent progenitor cells commit to the desired cell

178 e of differentiated tissue-specific stem and multipotent progenitor cells for regenerative medicine a

179 Cell fate choice and commitment of multipotent progenitor cells to a differentiated lineage

180 , the biological secretome of Amnion-derived Multipotent Progenitor cells, contains multiple anti-inf

181 their order; the final mutations occur in a multipotent progenitor derived from the preleukemic HSC

182 Currently, the patterns of multipotent progenitor divisions that lead to neurogenic

183 tiation and that inhibition of Ezh2 promotes multipotent progenitor expansion.

184 epithelium of the branching mouse lung is a multipotent progenitor pool that self-renews and produce

185 the expansion had shifted to the phenotypic multipotent progenitor population by 1 year.

186 Multipotent progenitor populations are necessary for gen

187 , in subsets of hematopoietic stem cells and multipotent progenitor populations.

188 28a and tnfalpha genes, which are related to multipotent progenitor proliferation.

189 olecular network wiring helps to establish a multipotent progenitor state, with experimental approach

190 by modulating transcription, thus impacting multipotent progenitor states and subsequent fate choice

191 ey transit into short-term self-renewing and multipotent progenitor states, with the first major line

192 We have described multipotent progenitor-like cells within the major pancr

193 erentiation of haematopoietic stem cells and multipotent progenitors (HSC/MPPs) but remains poorly de

194 However, how multipotent progenitors (MPP) switch into common lymphoi

195 wounding increases myeloid lineage-committed multipotent progenitors (MPP3 subset) and Mo in bone mar

196 ction, lineage specification at the level of multipotent progenitors (MPPs) remains poorly understood

197 s of the composition of HSCs and HSC-derived multipotent progenitors (MPPs) revealed a significantly

198 cells (HSCs), short-term HSCs (ST-HSCs), and multipotent progenitors (MPPs) were all significantly re

199 ownstream of hematopoietic stem cells (HSCs)/multipotent progenitors (MPPs).

200 ls, i.e. hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs).

201 ed depletion of hematopoietic stem cells and multipotent progenitors across all subtypes.

202 ubsets of these cells can differentiate from multipotent progenitors and committed T cell precursors

203 mouse young adult and old adult mouse HSCs, multipotent progenitors and oligopotent progenitors; 12

204 homed HSCs in bone marrow and spleen became multipotent progenitors and, occasionally, some HSCs gav

205 opoietic precursors with IL-1, we found that multipotent progenitors are targets of IL-1.

206 ensure precision in lineage specification as multipotent progenitors become restricted in cell fate.

207 rm, but the chromatin landscapes that govern multipotent progenitors competence and early fate choice

208 ferentiation recapitulates the generation of multipotent progenitors during embryonic development, wh

209 Muller glia (MG) to proliferate and generate multipotent progenitors for retinal repair.

210 These multipotent progenitors have a high proliferation abilit

211 We further show that adenosine increased multipotent progenitors in a mouse embryonic stem cell c

212 ecific progenitors, we identify bipotent and multipotent progenitors in ducts and TDLUs, respectively

213 yelopoiesis caused by epigenetic rewiring of multipotent progenitors in the bone marrow, which overco

214 sion between endocrine and exocrine fates of multipotent progenitors in the developing pancreas, and

215 An increase in the cellularity of multipotent progenitors is observed in young Dok1/Dok2-d

216 How these cell types arise from multipotent progenitors is poorly understood.

217 In vertebrates, multipotent progenitors located in the pharyngeal mesode

218 or 1 complex (Paf1C) is required to maintain multipotent progenitors of the neural crest (NC) lineage

219 These multipotent progenitors of the spleen (MPPS) develop fro

220 These multipotent progenitors originate from Eya1-expressing o

221 During T cell development, multipotent progenitors relinquish competence for other

222 ferentiation of lineage-committed cells from multipotent progenitors requires the establishment of ac

223 forming haematopoietic stem cells (HSCs) and multipotent progenitors results in more aggressive AML t

224 Neural stem cells (NSCs) are multipotent progenitors that are responsible for produci

225 layer was damaged, MG respond by generating multipotent progenitors that migrate to all nuclear laye

226 nation of key transcription factors (TFs) in multipotent progenitors that transition them away from o

227 6 deficiency increased the ratio of Flt3(hi) multipotent progenitors to CD150(+) stem cells in the mo

228 An FGF-Foxf pathway acts in multipotent progenitors to establish cardiopharyngeal-sp

229 Two important TFs for the multipotent progenitors to T lineage transition are RUNX

230 HSCs and multipotent progenitors type 2 (MPP2), but not MPP3/4, w

231 urvived up to a year and showed expansion of multipotent progenitors, aberrant lymphopoiesis and thro

232 tors, including hematopoietic stem cells and multipotent progenitors, and increases the frequency of

233 es, implying that cells in the CE domain are multipotent progenitors, and suggesting that an asymmetr

234 egulated in SDS hematopoietic stem cells and multipotent progenitors, but not in lineage-committed pr

235 GM-CSF-receptor is increased on HSCs and multipotent progenitors, favoring a striking increase in

236 ation and differentiation of tissue-specific multipotent progenitors, lineage-specific transcriptiona

237 show cell biological features different from multipotent progenitors, raising the possibility that an

238 first major lineage commitment occurring in multipotent progenitors, thus giving rise to progenitors

239 ls (EpiSCs) are an effective source of these multipotent progenitors, which are further differentiate

240 -erythrocyte progenitors and lymphoid-primed multipotent progenitors.

241 roles in inducing cell differentiation from multipotent progenitors.

242 endent on Runx1, a factor already present in multipotent progenitors.

243 sea star larvae begins with soxc-expressing multipotent progenitors.

244 stem cells that changes during transition to multipotent progenitors.

245 e for the directed homing mechanism of these multipotent progenitors.

246 otoreceptor damage and mitotic activation of multipotent progenitors.

247 4)/CD26 expression are highly proliferative, multipotent progenitors.

248 differentiated cells to dedifferentiate into multipotent proliferative cells with the capacity to reg

249 adult sheath tissues possess clonogenic and multipotent properties comparable to those of stem/proge

250 diate progenitors (IPs) are derived from the multipotent radial glia (RGs) and serve as the direct pr

251 teraction in the regulation of Six2-positive multipotent renal progenitor cells and formation of the

252 Multipotent retinal progenitor cells (RPCs) generate var

253 es, retinal ganglion cells (RGCs) arise from multipotent retinal progenitor cells (RPCs), and their f

254 A single pool of multipotent retinal progenitor cells give rise to the di

255 How multipotent retinal progenitors know when to switch from

256 ows that, whereas the prostate develops from multipotent SCs, only unipotent SCs mediate mammary glan

257 Multipotent self-renewing haematopoietic stem cells (HSC

258 Multipotent skin-derived precursors (SKPs), which exhibi

259 Multipotent Sox2-expressing skin-derived precursor (SKP)

260 ed stem cell-like cells (iMuSCs) displayed a multipotent state with sensitiveness and strong migratio

261 maintains eye field neural progenitors in a multipotent state; then, in combination with Pax6, Tbx3

262 imary somatic cells into tissue-regenerative multipotent stem (iMS) cells.

263 ression was restricted to the most immature, multipotent stem and progenitor populations.

264 ither frozen, nor fresh hAFSCs cultivated in multipotent stem cell culture conditions expressed OCT4A

265 er gene expression, and differentiation of a multipotent stem cell line.

266 A challenge has been to obtain multipotent stem cells and/or progenitors that can gener

267 aryocyte differentiation apparent from early multipotent stem cells in myelofibrosis and associated a

268 e of soluble cues directs differentiation of multipotent stem cells into discrete populations of spec

269 Terminal differentiation of multipotent stem cells is achieved through a coordinated

270 t population of central nervous system (CNS) multipotent stem cells known as oligodendrocyte progenit

271 T-IPs did not include multipotent stem cells or molecular evidence of T cell-r

272 Neural crest (NC) cells are multipotent stem cells that arise from the embryonic ect

273 rise via a hierarchical scheme starting with multipotent stem cells that become increasingly restrict

274 e neural crest is an embryonic population of multipotent stem cells that form numerous defining featu

275 opoietic stem cells (HSCs) are self-renewing multipotent stem cells that generate mature blood lineag

276 ne neural progenitor cells (NPCs), which are multipotent stem cells that give rise to cells in the ce

277 C-MSCs), originating in Wharton's jelly, are multipotent stem cells that home to damaged tissues and

278 Multipotent stem cells with neural crest-like properties

279 vital for the differentiation of ES cells to multipotent stem cells, little is known regarding the ro

280 for lineage choice and differentiation from multipotent stem cells.

281 y gland evokes cell dedifferentiation into a multipotent stem-like state, suggesting this to be a mec

282 mouse of a previously unknown population of multipotent stem/progenitor cells that are capable of no

283 neuronal precursors to dedifferentiate into multipotent stem/progenitor cells that contribute signif

284 ation and maintenance of bone marrow-derived multipotent stromal cells (BMSCs) that contribute to wou

285 silencing SMS in human bone marrow - derived multipotent stromal cells (MSCs) derived from healthy do

286 Transplantation of mesenchymal stem cells/multipotent stromal cells (MSCs) has been proposed to au

287 identify that white adipose tissue-resident multipotent stromal cells (WAT-MSCs) can act as a reserv

288 Mesenchymal stem cells (MSCs) are multipotent stromal cells within the bone marrow.

289 arrow stromal cells (BMSCs), a major type of multipotent stromal cells, produces pain relief (antihyp

290 ective differentiation of naive T cells into multipotent T cells is of great interest clinically for

291 Long-lived, self-renewing, multipotent T memory stem cells (TSCM) can trigger profo

292 Multipotent Tet2(-/-);Flt3(ITD) progenitors (LSK CD48(+)

293 the current view of endogenous pericytes as multipotent tissue-resident progenitors and suggest that

294 o function as mesenchymal stem cells (MSCs), multipotent tissue-resident progenitors with great poten

295 ults in differential fate acquisition in the multipotent trophectoderm leading to the formation of a

296 Multipotent trophoblasts undergo dynamic morphological m

297 m-like cells represent poorly differentiated multipotent tumor-propagating cells that contribute disp

298 animal stem cell niches, maintain a pool of multipotent, undifferentiated cells that divide and diff

299 -Ras-Raf-ERK cascade initiates patterning of multipotent vulval precursor cells (VPCs) of Caenorhabdi

300 These HSCs are fully multipotent, yet they display both higher lymphoid cell